Literature DB >> 23560368

Chemotherapy and immunomodulation: from immunogenic chemotherapies to novel therapeutic strategies.

Francois Ghiringhelli, Lionel Apetoh.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23560368     DOI: 10.2217/fon.12.207

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  6 in total

Review 1.  Dysfunction of antigen processing and presentation by dendritic cells in cancer.

Authors:  Joanna Bandola-Simon; Paul A Roche
Journal:  Mol Immunol       Date:  2018-04-05       Impact factor: 4.407

2.  Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy.

Authors:  David Escors
Journal:  New J Sci       Date:  2014-01-05

3.  Immune cell-based screening assay for response to anticancer agents: applications in pharmacogenomics.

Authors:  Amber Frick; Yuri Fedoriw; Kristy Richards; Blossom Damania; Bethany Parks; Oscar Suzuki; Cristina S Benton; Emmanuel Chan; Russell S Thomas; Tim Wiltshire
Journal:  Pharmgenomics Pers Med       Date:  2015-02-26

4.  Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model.

Authors:  Leah A Mitchell; Fernando Lopez Espinoza; Daniel Mendoza; Yuki Kato; Akihito Inagaki; Kei Hiraoka; Noriyuki Kasahara; Harry E Gruber; Douglas J Jolly; Joan M Robbins
Journal:  Neuro Oncol       Date:  2017-07-01       Impact factor: 12.300

Review 5.  Nanomedicine-enabled chemotherapy-based synergetic cancer treatments.

Authors:  Wencheng Wu; Yinying Pu; Jianlin Shi
Journal:  J Nanobiotechnology       Date:  2022-01-04       Impact factor: 10.435

Review 6.  Trial Watch: Chemotherapy with immunogenic cell death inducers.

Authors:  Erika Vacchelli; Fernando Aranda; Alexander Eggermont; Jérôme Galon; Catherine Sautès-Fridman; Isabelle Cremer; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-03-01       Impact factor: 8.110

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.